Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2026)
Inspire Medical Systems (INSP) reported Total Non-Current Liabilities of $119.0 million for Q1 2026, up 25.29% on a YoY basis from $95.0 million in Q1 2025, and down 5.62% sequentially from $126.1 million in Q4 2025.
Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Inspire Medical Systems (INSP) has 10 years of Total Non-Current Liabilities data on file, last reported at $119.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 25.29% year-over-year to $119.0 million; the trailing twelve-month figure through Mar 2026 stood at $119.0 million (up 25.29% YoY), and the FY2025 full-year result was $126.1 million, up 6.34% from the prior year.
- Total Non-Current Liabilities eased to $119.0 million in Q1 2026, from $126.1 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $141.1 million in Q3 2025 to a low of $57.2 million in Q3 2022.
- A 5-year average of $95.3 million and a median of $95.2 million in 2023 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities slipped 2.22% in 2022 and jumped 66.46% in 2023, its largest moves.
- Tracing INSP's Total Non-Current Liabilities over 5 years: stood at $68.7 million in 2022, then soared by 49.81% to $103.0 million in 2023, then rose by 15.14% to $118.5 million in 2024, then climbed by 6.34% to $126.1 million in 2025, then fell by 5.62% to $119.0 million in 2026.
- Business Quant data shows INSP's Total Non-Current Liabilities at $119.0 million in Q1 2026, $126.1 million in Q4 2025, and $141.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | 2.64 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 24.21 Bn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 3.53 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 3.57 Bn |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | 9.85 Bn |
| 10 | Inspire Medical Systems | 1.46 Bn | 1.18 Bn | 176.91 Mn | 118.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.97 Mn |
| Dec 31, 2025 | 126.05 Mn |
| Sep 30, 2025 | 141.15 Mn |
| Jun 30, 2025 | 124.27 Mn |
| Mar 31, 2025 | 94.96 Mn |
| Dec 31, 2024 | 118.54 Mn |
| Sep 30, 2024 | 99.48 Mn |
| Jun 30, 2024 | 90.17 Mn |
| Mar 31, 2024 | 96.67 Mn |
| Dec 31, 2023 | 102.95 Mn |
| Sep 30, 2023 | 95.17 Mn |
| Jun 30, 2023 | 88.74 Mn |
| Mar 31, 2023 | 67.05 Mn |
| Dec 31, 2022 | 68.72 Mn |
| Sep 30, 2022 | 57.17 Mn |
| Jun 30, 2022 | 64.87 Mn |
| Mar 31, 2022 | 64.52 Mn |
| Dec 31, 2021 | 65.90 Mn |
| Sep 30, 2021 | 58.47 Mn |
| Jun 30, 2021 | 52.18 Mn |